Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Ingredients News

Tetraphase hires Patheon to make its synthetic antibiotic eravacycline

22-Jun-2017 - Tetraphase Pharmaceutical has hired Patheon UK Limited to make and test the synthetic antibiotic eravacycline.

US bans drugs and all but one API made at three IPCA Labs plants

21-Jun-2017 - The US FDA has banned all drugs and all but one of the APIs made by Ipca Laboratories at its facilities in Ratlam, Indore and Piparia.

Anhui Sunhere awarded patent for enzyme-based starch solubilization method

20-Jun-2017 - Anhui Sunhere Pharmaceutical Excipients has been granted a Chinese patent for an enzyme-based method of making starch soluble.

A change of focus: B-MS sells Irish API plant to Korean SK Biotek

19-Jun-2017 - Bristol-Myers Squibb (B-MS) has announced it will sell its Swords, Ireland-based API manufacturing facility as part of its focus on biologics.

Update with comment from MHRA

Europe tells API firms UK will be a “third country” like India and China after Brexit

15-Jun-2017 - The European Commission has confirmed that UK drug ingredient manufacturers will have to supply European customers with written confirmation their products are made in compliance with EU standards after Brexit.


AstraZeneca made Eliquis recalled in US says Bristol Myers-Squibb

15-Jun-2017 - Bristol Myers Squibb (B-MS) says the lot of Eliquis recalled in the US this week was made by AstraZeneca’s contract manufacturing business.

Dr Reddy's says US FDA has closed Miryalaguda plant audit

14-Jun-2017 - Dr Reddy’s Laboratories says it has addressed the problems that earned its API plant in Miryalaguda, Talangana a US FDA Form 483 earlier this year.

News in brief

Johnson Matthey teams with Intrexon to make peptide API production more efficient

13-Jun-2017 - Johnson Matthey and Intrexon Corporation have teamed up to develop peptide active pharmaceutical ingredient (API) production methods.

Eurofins buys drug ingredient contractor Alphora Research

13-Jun-2017 - Eurofins Scientific has acquired drug ingredient manufacturing and testing services firm Alphora Research, Inc.

Update - BioMarin to hire 50 people at Shanbally

US FDA clears BioMarin to make $380,000-a year Vimizim in Ireland

12-Jun-2017 - The US FDA has cleared BioMarin Pharmaceutical Inc. to make the enzyme replacement drug Vimizim (elosulfase alfa) at its plant in Cork, Ireland.

Cure & cancer: cannabis molecule blend research

12-Jun-2017 - Cure Pharmaceutical has entered into a strategic collaboration to test and develop potential cancer therapeutics utilising a blend of the cannabis plant-derived terpenes. 

BASF ups costs of BDO intermediates to restore margins after demand picks up

07-Jun-2017 - BASF has raised prices in Europe by as much as €300 per metric ton as demand returns for its butanediol-based chemicals.

AMRI set to be acquired by private equity

06-Jun-2017 - Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.

Roquette expands into Brazilian pharma excipient space

06-Jun-2017 - Ingredients manufacturer Roquette says it will acquire Blancer’s Brazil-based excipient division, Itacel, to meet market demand.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 - Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

Spider silk challenges cost of biological lung surfactant

31-May-2017 - Researchers at Sweden-based Karolinska Institutet have developed a synthetic lung surfactant using DNA sequences derived from spider silk proteins.

Granules India confirms $35m US plant expansion will create jobs

24-May-2017 - Granules India says adding manufacturing capacity at its facility in Virginia, US will create 102 jobs.

DSM Sinochem wins patent infringement ruling against Sinopharm Weiqida

23-May-2017 - The High Court of Delhi, India, has granted a permanent injunction against Sinopharm Weiqida Pharmaceutical for patent infringement of DSM Sinochem Pharmaceuticals’ enzyme-based antibiotic production IP.

IFPMA launches Alliance to track drug firms' progress in the fight against ‘superbugs'.

Charity urges drug industry to consider supplier role in “superbug” spread

18-May-2017 - Drug manufacturers, retail pharmacies and regulators have a role to play in curbing antimicrobial resistance say campaigners urging industry to ensure their API suppliers are not part of the problem.

CEFIC: members will only sell GHB intermediate to legitimate industry users

18-May-2017 - Cefic has agreed to make sure its members only sell the intermediate gamma butyrolactone (GBL) to legitimate users to stop it being abused or used in “date rape” drug GHB.

Coming to America: Evolving pharma landscape brings CPhI to Philadelphia

16-May-2017 - With almost 40% of attendees coming from outside the US, the political climate has had no effect on the latest CPhI franchise which starts today in Philadelphia.

CPhI North America debuts in Philadelphia

16-May-2017 - [View the story "CPhI North America debuts in Philadelphia" on Storify]

Italian regulators find problems at Kores' API plant in Roha

10-May-2017 - Italian regulators say Kores Limited’s facility in Roha, India should be banned from supplying the API ambroxol hydrochloride to the EU and advised users to find an alternative source.

Vikshara says plant banned by US FDA has stopped making APIs

10-May-2017 - The US FDA has accused Vikshara Trading & Investments Ltd. of giving false statements about a strike to delay the inspection of an Ahmedabad API plant later found to be non-compliant.

PE backer stumps up $12.3m to help Teewinot grow cannabinoid business

03-May-2017 - Teewinot Life Sciences has closed a $12.3m (€11.2m) deal with investment manager Tuatara Capital.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...